Global angioscope devices market is projected to grow at a CAGR of XX% during the forecast period to reach US $XX billion by 2023 from US $XX billion in 2017. Angioscope is a flexible endoscopic devices that is used to assess and examine the interior of the blood vessel and is more accurate in identifying and treating blood vessel obstructions. Angioscope is used to assess vascular diseases, thrombus composition and staging of atherosclerosis. The advantages of the angioscope is onsite bypass process for direct visualization of valves and it also provides the insight about the treatments that should be given to patient for best outcomes. Increase in ageing population coupled with the rise in prevalence of cardiovascular disease is rapidly driving the need of angioscope devices globally. Moreover, rising prevalence of lifestyle diseases such as hypertension, diabetes and atherosclerosis are not only increasing the risk of cardiovascular diseases but also raising the demand for angioscope devices for treatment and diagnostic purpose.
Main driver of the angioscope device market is increasing investment by the companies and government funding in the research and development of the angioscope devices. Improving healthcare infrastructure in developing countries and increasing adoption of minimally invasion procedures is also the reason for growth of the market. However, high cost of the equipment coupled with unfavourable reimbursement policies in developing countries are the major factors which restrain the growth of the angioscope device market. Despite the restraint, the global angioscope device market is estimated to show a robust growth during the forecast period.
Geographically, the global angioscope device market is segmented as North America, Europe, South America, Middle East and Africa, and Asia-Pacific. North America and Europe enjoy a favourable market share owing to the rise in lifestyle disease and cardiovascular disease along with the convenient reimbursement policies in both the regions. Asia-Pacific region has substantial market growth potential owing to the rising investment in healthcare infrastructure and rising awareness about the cardiovascular diseases.
The global angiocope device market is highly competitive due to presence of huge consumer base and presence of well-established players such as Olympus. The growing need for adoption of existing technology, intense competition and further investment on technological upgrades is paving the way for mergers and acquisitions by big market players to boost their market presence. Competitive landscape details, products, strategies, and investments being done by key companies has been provided in the report.
Some of the major players discussed in this report are LeMaitre Vascular, Inc., Fibertech Co. Ltd, Olympus Corporation, B. Braun Melsungen AG, Karl Storz SE & Co. KG and VerAvanti.
The global angioscope device market has been segmented by component, application, end-user and geography.
Middle East and Africa
Key insights offered
What will be the global angioscope device market size from 2017 to 2023?
How are the major drivers and restraints affecting the global angioscope device market growth and the opportunities which exist for key vendors?
Which segment and region will drive or lead the market growth and why?
A comprehensive analysis of competitive landscape and key market participants’ behaviour
Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.